chr10-119030030-CCCT-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP6_Very_StrongBS2

The NM_199461.4(NANOS1):​c.240_242delCTC​(p.Ser81del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.006 in 1,385,068 control chromosomes in the GnomAD database, including 36 homozygotes. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0058 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0060 ( 35 hom. )

Consequence

NANOS1
NM_199461.4 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts P:1B:4

Conservation

PhyloP100: 2.57

Publications

2 publications found
Variant links:
Genes affected
NANOS1 (HGNC:23044): (nanos C2HC-type zinc finger 1) This gene encodes a CCHC-type zinc finger protein that is a member of the nanos family. This protein co-localizes with the RNA-binding protein pumilio RNA-binding family member 2 and may be involved in regulating translation as a post-transcriptional repressor. Mutations in this gene are associated with spermatogenic impairment. [provided by RefSeq, Sep 2015]
NANOS1 Gene-Disease associations (from GenCC):
  • male infertility with azoospermia or oligozoospermia due to single gene mutation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • spermatogenic failure 12
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP6
Variant 10-119030030-CCCT-C is Benign according to our data. Variant chr10-119030030-CCCT-C is described in ClinVar as Benign. ClinVar VariationId is 65390.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 865 AD,Unknown gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_199461.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NANOS1
NM_199461.4
MANE Select
c.240_242delCTCp.Ser81del
disruptive_inframe_deletion
Exon 1 of 1NP_955631.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NANOS1
ENST00000425699.3
TSL:6 MANE Select
c.240_242delCTCp.Ser81del
disruptive_inframe_deletion
Exon 1 of 1ENSP00000393275.1

Frequencies

GnomAD3 genomes
AF:
0.00577
AC:
865
AN:
149962
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00136
Gnomad AMI
AF:
0.00220
Gnomad AMR
AF:
0.00106
Gnomad ASJ
AF:
0.00526
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000829
Gnomad FIN
AF:
0.0337
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00642
Gnomad OTH
AF:
0.00194
GnomAD2 exomes
AF:
0.00376
AC:
147
AN:
39138
AF XY:
0.00391
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000967
Gnomad ASJ exome
AF:
0.00252
Gnomad EAS exome
AF:
0.000745
Gnomad FIN exome
AF:
0.0189
Gnomad NFE exome
AF:
0.00526
Gnomad OTH exome
AF:
0.00244
GnomAD4 exome
AF:
0.00603
AC:
7446
AN:
1234998
Hom.:
35
AF XY:
0.00584
AC XY:
3529
AN XY:
604126
show subpopulations
African (AFR)
AF:
0.000671
AC:
17
AN:
25350
American (AMR)
AF:
0.000683
AC:
13
AN:
19024
Ashkenazi Jewish (ASJ)
AF:
0.00382
AC:
76
AN:
19884
East Asian (EAS)
AF:
0.0000369
AC:
1
AN:
27088
South Asian (SAS)
AF:
0.00146
AC:
85
AN:
58302
European-Finnish (FIN)
AF:
0.0257
AC:
766
AN:
29822
Middle Eastern (MID)
AF:
0.000266
AC:
1
AN:
3762
European-Non Finnish (NFE)
AF:
0.00623
AC:
6243
AN:
1001540
Other (OTH)
AF:
0.00486
AC:
244
AN:
50226
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
386
771
1157
1542
1928
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
258
516
774
1032
1290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00576
AC:
865
AN:
150070
Hom.:
1
Cov.:
32
AF XY:
0.00698
AC XY:
511
AN XY:
73236
show subpopulations
African (AFR)
AF:
0.00135
AC:
56
AN:
41360
American (AMR)
AF:
0.00105
AC:
16
AN:
15168
Ashkenazi Jewish (ASJ)
AF:
0.00526
AC:
18
AN:
3422
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5096
South Asian (SAS)
AF:
0.000830
AC:
4
AN:
4820
European-Finnish (FIN)
AF:
0.0337
AC:
335
AN:
9936
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00642
AC:
430
AN:
66984
Other (OTH)
AF:
0.00192
AC:
4
AN:
2082
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
44
87
131
174
218
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00245
Hom.:
0
Bravo
AF:
0.00311

ClinVar

Significance: Benign
Submissions summary: Pathogenic:1Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Spermatogenic failure 12 Pathogenic:1Benign:1
Mar 01, 2013
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

Jan 06, 2020
Reproductive Health Research and Development, BGI Genomics
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:curation

NM_199461.2:c.240_242delCTC in the NANOS1 gene has an allele frequency of 0.022 in European (Finnish) subpopulation in the gnomAD database. This in-frame deletion happens in a repetitive region without known function. Kusz-Zamelczyk et al. reported this variant as p.Pro77_Ser78delinsPro (PMID: 23315541). Using the quantitative yeast two-hybrid assay, the author tested both mutated NANOS1 alleles for interaction with GEMIN3, and found that the p.Pro34Thr, p.Pro77_Ser78delinsPro allele reduced interaction with GEMIN3 by 14% (PMID: 23315541). In one pedigree, the variant segregate with the phenotype. In contrary, in the second pedigree (patient 2), the father passed this variant to his son, indicating his father is fertile although he has this variant. Taken together, we interprete this variant as Benign/Likely benign variant (PMID: 23315541). ACMG/AMP criteria applied: BS1, BP3.

not provided Benign:2
Aug 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

NANOS1: PM4:Supporting, BS1, BS2

Jan 23, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

NANOS1-related disorder Benign:1
Mar 16, 2021
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
2.6
Mutation Taster
=75/25
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs587777031; hg19: chr10-120789542; API